NDTV Profit
Home | Live TV | Videos | Expect $125-150 Mn From Oral Contraceptives Business: Lupin

Expect $125-150 mn from oral contraceptives business: Lupin

loading..
Lupin has received approval to launch the generic version of oral contraceptive Yasmin in the US. Ramesh Swaminathan, president of finance and planning, Lupin, explains this is a crucial product for the pharma company and could help them garner $125-150 million dollars over time. He adds that Lupin has a strong pipeline of launches for the year ahead as well.

Advertisement

Advertisement

GAINERS / LOSERS

Advertisement